NFKB1 and cancer: At moderate concentration, ROS can actuate several cancer cell survival signaling cascades, viz., MAPK/ERK1/2, P38, JNK (c-Jun N-terminal kinase), and PI3K/Akt, which, in turn, trigger the activation of NF-kB, VEGF, and MMP activation [55].